Pmv Pharmaceuticals Company Insiders
PMVP Stock | USD 1.74 0.04 2.25% |
Pmv Pharmaceuticals' insiders are aggressively selling. The analysis of the overall insider sentiment regarding Pmv Pharmaceuticals suggests that virtually all insiders are panicking. Pmv Pharmaceuticals employs about 63 people. The company is managed by 13 executives with a total tenure of roughly 147 years, averaging almost 11.0 years of service per executive, having 4.85 employees per reported executive.
Pmv Pharmaceuticals' Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
2024-09-11 | Michael Carulli | Disposed 2891 @ 1.5 | View | ||
2023-11-22 | Orbimed Advisors Llc | Disposed 87786 @ 2.23 | View |
Monitoring Pmv Pharmaceuticals' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Pmv |
Pmv Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (0.2027) % which means that it has lost $0.2027 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2363) %, meaning that it created substantial loss on money invested by shareholders. Pmv Pharmaceuticals' management efficiency ratios could be used to measure how well Pmv Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/11/2024, Return On Tangible Assets is likely to drop to -0.29. In addition to that, Return On Capital Employed is likely to drop to -0.35. At this time, Pmv Pharmaceuticals' Liabilities And Stockholders Equity is relatively stable compared to the past year. As of 11/11/2024, Non Current Liabilities Other is likely to grow to about 16.2 M, while Total Current Liabilities is likely to drop slightly above 9.2 M.As of 11/11/2024, Common Stock Shares Outstanding is likely to drop to about 47.3 M. In addition to that, Net Loss is likely to drop to about (69.3 M)
Pmv Pharmaceuticals Workforce Comparison
Pmv Pharmaceuticals is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 128. Pmv Pharmaceuticals totals roughly 63.0 in number of employees claiming about 49% of equities under Health Care industry.
Pmv Pharmaceuticals Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Pmv Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Pmv Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Pmv Pharmaceuticals insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Pmv Pharmaceuticals Notable Stakeholders
A Pmv Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Pmv Pharmaceuticals often face trade-offs trying to please all of them. Pmv Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Pmv Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Laura Leon | VP Operations | Profile | |
Leila MD | Chief Officer | Profile | |
Winston MBA | COO CFO | Profile | |
Marc MD | Senior Affairs | Profile | |
Tim Smith | Senior Relations | Profile | |
Robert Ticktin | Head Counsel | Profile | |
Deepika PharmD | Chief Officer | Profile | |
Crystal Zuckerman | Vice Resources | Profile | |
Arnold Levine | Independent CoFounder | Profile | |
Michael Carulli | Chief Officer | Profile | |
Binh Vu | Senior CMC | Profile | |
Thomas Shenk | CoFounder Board | Profile | |
David Mack | CEO, CoFounder | Profile |
About Pmv Pharmaceuticals Management Performance
The success or failure of an entity such as Pmv Pharmaceuticals often depends on how effective the management is. Pmv Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pmv management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pmv management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.27) | (0.29) | |
Return On Capital Employed | (0.34) | (0.35) | |
Return On Assets | (0.27) | (0.29) | |
Return On Equity | (0.31) | (0.29) |
Pmv Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Pmv Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Pmv Pharmaceuticals within its industry.Pmv Pharmaceuticals Manpower Efficiency
Return on Pmv Pharmaceuticals Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 1.1M | |
Net Loss Per Executive | 5.3M | |
Working Capital Per Employee | 3.1M | |
Working Capital Per Executive | 14.9M |
Additional Tools for Pmv Stock Analysis
When running Pmv Pharmaceuticals' price analysis, check to measure Pmv Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv Pharmaceuticals is operating at the current time. Most of Pmv Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pmv Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pmv Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.